Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (1) , 411-414
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Factor XIII deficiency diagnosis: Challenges and toolsInternational Journal of Laboratory Hematology, 2017
- Blood coagulation factor XIII and factor XIII deficiencyBlood Reviews, 2016
- Diagnosis and Management of Congenital and Acquired FXIII DeficienciesSeminars in Thrombosis and Hemostasis, 2016
- Factor XIII: Structure and FunctionSeminars in Thrombosis and Hemostasis, 2016
- Diagnosis of factor XIII deficiencyHematology, 2016
- Clinical features of 32 new Japanese cases with autoimmune haemorrha‐philia due to anti‐factor XIII antibodiesHaemophilia, 2015
- Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapyHaemophilia, 2013
- Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determinationHaemophilia, 2011
- As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in JapanThrombosis and Haemostasis, 2011
- Factor XIII DeficiencySeminars in Thrombosis and Hemostasis, 2009